Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-08-25

Clinical Trial Update: Pembrolizumab, Combination Chemotherapy, and Radiation Therapy Before Surgery in Treating Adult Patients With Locally Advanced Gastroesophageal Junction or Gastric Cardia Cancer That Can Be Removed by Surgery [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 study evaluating pembrolizumab with chemotherapy and radiation before surgery for locally advanced gastroesophageal junction or gastric cardia adeno…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pembrolizumab (Keytruda) (pembrolizumab)

Snippet

Sponsor: Mayo Clinic | Conditions: Gastric Cardia Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-08-25